Approval To Be Determined on Case-by-Case Basis
CAMBRIDGE, Mass., February 3, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that Statutory Health Insurance in Germany has approved MyoPro for patients on a case by case basis. A major German health insurer, BARMER, with 9 million covered lives, is covering the cost of the MyoPro provided through certified orthotics and prosthetics clinics in Germany. The first patient covered by BARMER has a paralyzed arm caused by a brachial plexus injury sustained in a skiing accident. Unable to use her hand and arm for almost 20 years, she will now have access to a MyoPro to restore movement and function in her arm and hand. Read more.